5-135535642-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006161.3(NEUROG1):āc.49A>Gā(p.Ser17Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000303 in 1,586,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006161.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG1 | NM_006161.3 | c.49A>G | p.Ser17Gly | missense_variant | 1/1 | ENST00000314744.6 | NP_006152.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG1 | ENST00000314744.6 | c.49A>G | p.Ser17Gly | missense_variant | 1/1 | NM_006161.3 | ENSP00000317580 | P1 | ||
ENST00000698884.1 | n.496+48873T>C | intron_variant, non_coding_transcript_variant | ||||||||
SLC25A48 | ENST00000698885.1 | n.364+25886T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000920 AC: 2AN: 217500Hom.: 0 AF XY: 0.00000831 AC XY: 1AN XY: 120374
GnomAD4 exome AF: 0.0000174 AC: 25AN: 1434088Hom.: 0 Cov.: 31 AF XY: 0.0000126 AC XY: 9AN XY: 713178
GnomAD4 genome AF: 0.000151 AC: 23AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.49A>G (p.S17G) alteration is located in exon 1 (coding exon 1) of the NEUROG1 gene. This alteration results from a A to G substitution at nucleotide position 49, causing the serine (S) at amino acid position 17 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at